Compare MiniMed Group Inc. Common Stock (MMED) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MiniMed Group Inc. Common Stock vs Roivant Sciences Ltd. Common Shares — how do they compare? MiniMed Group Inc. Common Stock trades at $19.53 (market cap $5.57B), while Roivant Sciences Ltd. Common Shares trades at $35.1 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 4.4× MiniMed Group Inc. Common Stock's market cap, and MiniMed Group Inc. Common Stock is more actively traded (23,336,073 versus 6,279,442). Which is the better fit depends on your goals — on Pluang, investors hold MiniMed Group Inc. Common Stock for 1 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.
| MMED | ROIV | |
|---|---|---|
Market Cap | $5.57B | $24.72B |
Volume | 23,336,073 | 6,279,442 |
Sector | Health | Health |
52-Week High | $23.84 | $41.81 |
52-Week Low | $10.80 | $16.04 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $5.37B | $20.99B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About MiniMed Group Inc. Common Stock
MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
